Plain-English translation of NCT07555470 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether two medications— and —work better when given together to treat follicular lymphoma. Follicular lymphoma is a slow-growing blood cancer that affects the immune system. Researchers believe combining these two medications may help more patients go into remission.
Currently, treatment options for follicular lymphoma are limited, especially for patients whose cancer comes back after previous treatment or who have high-risk disease. This study explores whether combining this medication with another approach could offer patients a more effective option.
You likely qualify if…
You likely don't qualify if…
The study happens in two stages. First, a small safety group of 6 people takes the medication for 28 days to make sure it is safe. Then the study expands to three larger groups based on your specific type of follicular lymphoma. You will visit the clinic regularly to receive the medication, have blood tests, and have imaging scans to see how well the treatment is working.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
China